Dasan Pharmaceutical Co., Ltd. (CEO Ryu Hyeong-seon), a specialized pharmaceutical CDMO company, announced on the 6th that it has obtained ESG certification and ISO 45001/14001 integrated certification to strengthen its sustainable management competitiveness across safety, environment, and governance.
In addition to obtaining certification for its ESG management system, Dasan Pharmaceutical also received integrated certification for the international standards ISO 45001 (Occupational Health and Safety Management System) and ISO 14001 (Environmental Management System). The company's existing ISO 45001 certification was recertified with ISO 14001, officially recognizing its comprehensive safety and environment management capabilities.
This certification recognizes Dasan Pharmaceutical's systematic pursuit of sustainable management based on environmental protection, industrial safety, social responsibility, and transparent governance. It is particularly significant for establishing and consistently operating a world-class safety and environmental management system.
ISO 45001 is an international standard for proactively managing potential workplace hazards and protecting the safety and health of workers. ISO 14001 stipulates environmental management system requirements to minimize the environmental impact of corporate activities. By integrating these two certifications, Dasan Pharmaceutical organically links safety and health with environmental management, simultaneously enhancing operational efficiency and risk management.
Furthermore, through ESG certification, the company has objectively verified its overall ESG management level, including environmentally friendly production processes, respect for employee safety, health, and human rights, ethical management, and transparent decision-making structures. This is recognized as a proactive response to the growing ESG demands in the global pharmaceutical and biotechnology industries.
Based on its future ISO 37001 (Anti-Corruption Management System) certification and this integrated ESG and ISO certification, Dasan Pharmaceutical plans to continue pursuing its ESG management strategy centered on preventing corruption, expanding investment in eco-friendly facilities, enhancing its safety and health management system, and strengthening ethical and compliance management.
- See more related articles
You must be logged in to post a comment.